Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-03-11

Clinical Trial Update: Glucocorticoid Inflammation Paradox in Human Skeletal Muscle [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial investigating glucocorticoid inflammation in human skeletal muscle has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Texas A&M University | Conditions: Aging | Phase 3 | Status: WITHDRAWN